Nektar Therapeutics (NKTR) Insider Trading & Ownership $1.20 +0.03 (+2.14%) As of 01:22 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Nektar Therapeutics (NASDAQ:NKTR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.71%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$362,555.35 Get NKTR Insider Trade Alerts Want to know when executives and insiders are buying or selling Nektar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NKTR Insider Buying and Selling by Quarter Ad Brownstone ResearchMan Who Called Nvidia Says: “Your Retirement Is Inside This Building.”In 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $3 trillion company... And the stock is up massively since Jeff's recommendation. Now, Jeff has found five under-the-radar stocks which could power your retirement. Nektar Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/23/2024Mark Andrew WilsonInsiderSell33,402$0.90$30,061.80 12/19/2024Jonathan ZalevskyInsiderSell51,115$0.94$48,048.10 12/17/2024Howard W RobinCEOSell46,995$1.01$47,464.95 11/19/2024Howard W RobinCEOSell16,278$1.01$16,440.78 11/19/2024Jonathan ZalevskyInsiderSell7,785$1.01$7,862.85 8/19/2024Howard W RobinCEOSell14,881$1.28$19,047.68 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/19/2024Jonathan ZalevskyInsiderSell6,866$1.28$8,788.48 6/14/2024Robert ChessDirectorSell19,500$1.20$23,400.00 5/17/2024Howard W RobinCEOSell16,650$1.75$29,137.50 5/17/2024Jonathan ZalevskyInsiderSell7,355$1.75$12,871.25 5/10/2024Deep Track Capital, LpMajor ShareholderSell56,000$1.78$99,680.00 2/20/2024Howard W RobinCEOSell20,033$0.68$13,622.44 2/20/2024Jonathan ZalevskyInsiderSell9,014$0.68$6,129.52 (Data available from 1/1/2013 forward) NKTR Insider Trading Activity - Frequently Asked Questions Who is on Nektar Therapeutics's Insider Roster? The list of insiders at Nektar Therapeutics includes Deep Track Capital, Lp, Gil M Labrucherie, Howard W Robin, Jillian B Thomsen, John Northcott, Jonathan Zalevsky, Karin Eastham, Mark Andrew Wilson, Myriam Curet, Robert Chess, and Roy A Whitfield. Learn more on insiders at NKTR. What percentage of Nektar Therapeutics stock is owned by insiders? 3.71% of Nektar Therapeutics stock is owned by insiders. Learn more on NKTR's insider holdings. Which Nektar Therapeutics insiders have been selling company stock? The following insiders have sold NKTR shares in the last 24 months: Deep Track Capital, Lp ($99,680.00), Howard W Robin ($224,616.44), Jillian B Thomsen ($30,801.00), Jonathan Zalevsky ($134,496.60), Mark Andrew Wilson ($30,061.80), Myriam Curet ($3,007.71), Robert Chess ($23,400.00), and Roy A Whitfield ($17,100.00). How much insider selling is happening at Nektar Therapeutics? Insiders have sold a total of 469,995 Nektar Therapeutics shares in the last 24 months for a total of $563,163.55 sold. Nektar Therapeutics Key ExecutivesMr. Howard W. Robin (Age 71)CEO, President & Director Compensation: $1.83M3 recent tradesMr. Mark A. Wilson (Age 52)Senior VP, Chief Legal Officer & Secretary Compensation: $749.99kDr. Jonathan Zalevsky Ph.D. (Age 49)Chief Research & Development Officer Compensation: $1.25MMs. Sandra A. Gardiner (Age 58)Interim Chief Financial Officer Vivian WuDirector of Investor Relations & Corporate AffairsMr. Robert BacciSenior Vice President of Human Resources & Facilities OperationsMs. Jennifer RuddockChief Business OfficerDr. Mary Tagliaferri L.Ac. (Age 58)M.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies PCRX Insider Buying OMER Insider Buying ASMB Insider Buying CPIX Insider Buying LLY Insider Buying JNJ Insider Buying ABBV Insider Buying MRK Insider Buying PFE Insider Buying BMY Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop BuyingAppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? This page (NASDAQ:NKTR) was last updated on 1/7/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredElon Musk says U.S. government is going bankruptIn 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredTrading 5-7 Stocks to Profit $1,300 a Day?If you want a straightforward, faster, and potentially more reliable way to trade… Learn this strategy by w...Prosper Trading Academy | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nektar Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Nektar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NKTR Stock Alerts